Document Classification

Section Type: RESULTS

Text: ET-1 infusion reduced AIR (G) (to 34. 85 + / - 4. 27 compared with 49. 3 + / - 6. 9 microU/ml during placebo, P = 0. 017) and the acute C-peptide response to glucose (to 2. 33 + / - 0. 41 compared with 3. 1 + / - 0. 44 ng/ml, P = 0. 018), decreased plasma insulin levels during the FSIGT compared with placebo (analysis of variance P < 0. 0001) and decreased the AUC (1-19) (to 2. 1 + / - 0. 2 compared with 2. 9 + / - 0. 3 U/l per 20 min, P < 0. 01) while phi1 tended to be lower.